Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023 H.R.7024 - Tax Relief for American Families and Workers Act of 2024 S.314 - Cost Recovery and Expensing Acceleration to Transform the Economy and Jumpstart Opportunities for Businesses and Startups Act S.866 - American Innovation and Jobs Act Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act/S.2333 - Pandemic and All-Hazards Preparedness and Response Act H.R. 5378: Lower Costs, More Transparency Act, S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 Issues related to commercial PBM Delinking, including House: DRUG ACT HR 6283, S. 1542. S.1375/H.R. 830 HELP Copays Act Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. S. 2764/H.R.5391 - Protecting Patient Access to Cancer and Complex Therapies Act H.R. 5378: Lower Costs More Transparency Act S. 3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 Issues related to Part D delinking of PBMs in H.R.2880 - Protecting Patients Against PBM Abuses Act, S.1967 - PBM Act H.R.5547/S. 476 - Maintaining Investments in New Innovation Act
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas) JOHN MCMANUS
Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas